Why I think this 20p penny stock could be set to explode in 2024

Jon Smith flags up a penny stock that he feels could outperform in the future due to growth in the cyber security division.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Front view photo of a woman using digital tablet in London

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

We’re all on the hunt for stocks that could generate a high return. Although penny stocks carry a higher level of risk than larger blue-chip firms, the small size does mean that large gains can be realised. Here’s one idea I’ve spotted that I think could shoot higher over the coming year.

A small firm with big potential

BATM Advanced Communications (LSE:BVC) is a tech company that focuses on two main areas. One is network and cyber security divisions and the other is bio-medical solutions.

Over the past year, the share price is down by 7%. With a current price of 20p, the market cap stands at £89m, making it a penny stock.

I like the company because I feel demand for the cyber security division in particular will increase over the next year. This is because we’re being warned that the rapid rise of artificial intelligence (AI) this year could have some unwanted side effects. One is that a rise of cyber attacks using AI is very likely. In fact, it’s already happening!

The Celare software that BATM sells is a secured network, and has good reviews. In fact, earlier this year it received a government cyber security order worth $26m. I’d expect revenue to increase next year with higher sales from this area.

Noting the location

One concern that needs to be flagged up is that the firm is headquartered in Israel. It does have offices around the world, but Israel is at war and there are negative economic impacts already being experienced in the country as a result.

However, the business doesn’t rely massively on any one physical location. Further, I don’t see the conflict with Hamas going on for a long period (which we all fervently hope). So I expect any impact on the firm to be limited.

The post-pandemic flush out

The stock might be familiar to some given the bio-medical solutions arm. It switched to help and make Covid-19 diagnostic kits during the pandemic. This saw the share price leap above 100p in 2020 as profits soared.

This demand has now gone, hence why the stock is much lower now. Yet I think that if the cyber security division can see high demand in the coming years due to AI-related attacks, we could see the stock jump.

Granted, a move of the magnitude of the one from the pandemic in such a short period of time is unlikely. Yet I believe that the profitability increase from software sales would be more sustainable than the Covid kits anyway. It’s not a flash in the pan, but rather a solution to a problem that I think will be here to stay.

As a result, I think investors should consider adding this penny stock to a portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Jon Smith has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Growth Shares

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

3 market-beating international investment funds for a Stocks and Shares ISA

It always pays to look for new ways to add extra diversity to a Stocks and Shares ISA. I think…

Read more »

Investing Articles

This FTSE 250 defence stock looks like a hidden growth gem to me

With countries hiking defence spending as the world grows more insecure, this FTSE 250 firm has seen surging orders and…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

2 FTSE 100 stocks I’d buy as the blue-chip index hits record highs

This Fool takes a look at a pair of quality FTSE 100 stocks that appear well-positioned for future gains, despite…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

These 7 UK shares turned £50k into £550k

Investing in individual UK shares can be a very lucrative strategy. Over the last two decades, these seven stocks have…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this FTSE growth superstar set to soar even higher on new drug results?

New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued…

Read more »

Investing Articles

Is the JD Sports share price set to explode?

Christopher Ruane considers why the JD Sports share price has done little over the past five years, even though sales…

Read more »

Smartly dressed middle-aged black gentleman working at his desk
Investing Articles

Rolls-Royce shares: tapped out at £4 or poised to climb further?

Rolls-Royce shares are finally showing signs of faltering after months of gains. Can they still climb further or is a…

Read more »